| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNISA996328047803316 |
|
|
Autore |
Dessì Schmid Sarah |
|
|
Titolo |
Aspectuality : An Onomasiological Model Applied to the Romance Languages / / Sarah Dessì Schmid |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Berlin ; ; Boston : , : De Gruyter, , [2019] |
|
©2020 |
|
|
|
|
|
|
|
|
|
ISBN |
|
3-11-056208-1 |
3-11-056410-6 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Soggetti |
|
Linguistics |
Semantics & pragmatics |
Grammar, syntax & morphology |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di contenuto |
|
Frontmatter -- Preface to English Edition -- Preface -- Contents -- Introduction -- 1. The Temporal Structuring of States of Affairs - Tense, Aspect and Aktionsart -- 2. The Aspectual Domain -- 3. Aspectuality as a Complex, Semantic, Universal Category. Theoretical and Methodological Foundations -- 4. The Model of Aspectuality as an Internal Temporal Structuring of States of Affairs -- 5. Combinations of the Dimensions of Aspectuality in the Situation Frame: the First Level of the Model Applied -- 6. The Second Level of the Aspectuality Model Applied -- 7. Closing Remarks -- Abbreviations -- References -- Author Index |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This synchronic study presents a new onomasiological, frame-theoretical model for the description, classification and theoretical analysis of the cross-linguistic content category aspectuality. It deals specifically with those pieces of information, which, in their interplay, constitute the aspectual value of states of affairs. The focus is on Romance Languages, although the model can be applied just as well to other languages, in that it is underpinned by a principle grounded in a fundamental cognitive ability: the delimitation principle. Unlike traditional approaches, which generally have a semasiological |
|
|
|
|
|
|
|
|
|
|
|
|
|
orientation and strictly adhere to a semantic differentiation between grammatical aspect and lexical aspect (Aktionsart), this study makes no such differentiation and understands these as merely different formal realisations of one and the same content category: aspectuality. |
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910774830103321 |
|
|
Autore |
Bobbio Norberto <1909-2004> |
|
|
Titolo |
L'esempio di Silvio Trentin : scritti 1954-1991 / / Norberto Bobbio; a cura di Pina Impagliazzo, Pietro Polito |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Firenze : , : Firenze University Press, , 2020 |
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (144 pages) : digital, PDF file(s) |
|
|
|
|
|
|
Collana |
|
Carte, Studi e Opere – Centro Trentin di Venezia ; ; 5 |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Politicians |
Political science - Philosophy |
Anti-fascist movements |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Sommario/riassunto |
|
As Norberto Bobbio writes in one of the essays included in this book, Silvio Trentin was an exceptional figure of a man of study and action, who never dissociates the commitment of the scholar from that of the militant, for whom, titles of the two famous essays by Max Weber, both school and politics are together, and not separately, a profession and a vocation. Not separately, and yet not confused. Trentin perfectly knew how to give science what it is of science and to politics what is of politics. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3. |
Record Nr. |
UNINA9910139209603321 |
|
|
Autore |
Machin David <1939-> |
|
|
Titolo |
Randomized clinical trials : design, practice, and reporting / / David Machin, Michael J. Campbell |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Chichester, West Sussex ; ; Hoboken, NJ, : John Wiley & Sons, 2010 |
|
|
|
|
|
|
|
ISBN |
|
1-282-68961-4 |
9786612689611 |
0-470-68623-5 |
0-471-49779-7 |
0-470-31922-4 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (375 p.) |
|
|
|
|
|
|
Classificazione |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Clinical trials |
Clinical trials - Statistical methods |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Randomized Clinical Trials; Contents; Preface; 1 Introduction; 1.1 Introduction; 1.2 Some completed trials; 1.3 Choice of design; 1.4 Practical constraints; 1.5 Influencing clinical practice; 1.6 History; 1.7 How trials arise; 1.8 Ethical considerations; 1.9 Regulatory requirements; 1.10 Focus; 1.11 Further reading; 2 Design Features; 2.1 Introduction; 2.2 The research question; 2.3 Patient selection; 2.4 The consent process; 2.5 Choice of interventions; 2.6 Choice of design; 2.7 Assigning the interventions; 2.8 Making the assessments; 2.9 Analysis and reporting; 2.10 Technical details |
2.11 Guidelines2.12 Further reading; 3 The Trial Protocol; 3.1 Introduction; 3.2 Protocol - abstract; 3.3 Protocol - background; 3.4 Protocol - research objectives; 3.5 Protocol - design; 3.6 Protocol - intervention details; 3.7 Protocol - eligibility; 3.8 Protocol - randomization; 3.9 Protocol - assessment and data collection; 3.10 Protocol - statistical considerations; 3.11 Protocol - ethical issues; 3.12 Protocol - organizational structure; 3.13 Protocol - publication policy; 3.14 Protocol - trial forms; 3.15 Protocol - appendices; 3.16 Regulatory requirements; 3.17 Guidelines |
|
|
|
|
|
|
|
|
|
|
|
3.18 Protocols4 Measurement and Data Capture; 4.1 Introduction; 4.2 Measures and endpoints; 4.3 Making the observations; 4.4 Baseline measures; 4.5 Types of measures; 4.6 Data recording; 4.7 Technical notes; 4.8 Guidelines; 5 Randomization; 5.1 Introduction; 5.2 Rationale; 5.3 Mechanics; 5.4 Application; 5.5 Carrying out randomization; 5.6 Documentation; 5.7 Unacceptable methods; 5.8 Software; 5.9 Guidelines; 6 Trial Initiation; 6.1 Introduction; 6.2 Trial organization; 6.3 Data collection and processing; 6.4 Data monitoring; 6.5 Ethical and regulatory requirements; 6.6 Launching the trial |
6.7 Trial registries6.8 Guidelines; 7 Trial Conduct; 7.1 Introduction; 7.2 Regular feedback; 7.3 Publicity; 7.4 Data monitoring committees; 7.5 Protocol modifications; 7.6 Preparing the publication(s); 7.7 The next trial?; 7.8 Protocols; 8 Basics of Analysis; 8.1 Introduction; 8.2 Confidence intervals; 8.3 Statistical tests; 8.4 Examples of analysis; 8.5 Other issues; 8.6 Practice; 8.7 Technical details; 9 Trial Size; 9.1 Introduction; 9.2 Significance level and power; 9.3 The fundamental equation; 9.4 Specific situations; 9.5 Practical considerations; 9.6 Further topics |
9.7 Other methods and software9.8 Guideline; 10 Reporting; 10.1 Introduction; 10.2 Publication guidelines; 10.3 Responsibilities; 10.4 Background; 10.5 Methods; 10.6 Findings; 10.7 When things go wrong; 10.8 Conclusions; 10.9 Guidelines; 11 Adaptations of the Basic Design; 11.1 Introduction; 11.2 Repeated measures; 11.3 Cluster-randomized trials; 11.4 Non-inferiority trials; 11.5 Guidelines; 12 Paired Designs; 12.1 Cross-over trials; 12.2 Split-mouth designs; 12.3 Paired organs; 13 More Than Two Interventions; 13.1 Introduction; 13.2 Unstructured comparisons |
13.3 Comparisons with placebo (or standard) |
|
|
|
|
|
|
Sommario/riassunto |
|
Using examples and case studies from industry, academia and research literature, Randomized Clinical Trials provides a detailed overview of the key issues involved in designing, conducting, analysing and reporting randomized clinical trials.? It examines the methodology for conducting Phase III clinical trials, developing the protocols, the practice for capturing, measuring, and analysing the resulting clinical data and their subsequent reporting. Randomized clinical trials are the principal method for determining the relative efficacy and safety of alternative treatments, interventio |
|
|
|
|
|
|
|
| |